These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19828199)

  • 1. Mutational and inhibitory analysis of a catalytic antibody. Implication for drug discovery.
    Phichith D; Bun S; Padiolleau-Lefèvre S; Banh S; Thomas D; Friboulet A; Avalle B
    Mol Immunol; 2009 Dec; 47(2-3):348-56. PubMed ID: 19828199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel peptide inhibiting both TEM-1 β-lactamase and penicillin-binding proteins.
    Phichith D; Bun S; Padiolleau-Lefevre S; Guellier A; Banh S; Galleni M; Frere JM; Thomas D; Friboulet A; Avalle B
    FEBS J; 2010 Dec; 277(23):4965-72. PubMed ID: 21044268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant.
    Mitsuda Y; Hifumi E; Tsuruhata K; Fujinami H; Yamamoto N; Uda T
    Biotechnol Bioeng; 2004 Apr; 86(2):217-25. PubMed ID: 15052642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving GPX activity of selenium-containing human single-chain Fv antibody by site-directed mutation based on the structural analysis.
    Xu J; Song J; Yan F; Chu H; Luo J; Zhao Y; Cheng X; Luo G; Zheng Q; Wei J
    J Mol Recognit; 2009; 22(4):293-300. PubMed ID: 19277948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the importance of second sphere residues in an esterolytic antibody by phage display.
    Arkin MR; Wells JA
    J Mol Biol; 1998 Dec; 284(4):1083-94. PubMed ID: 9837728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a functional scFv fragment of an anti-idiotypic antibody with a beta-lactam hydrolytic activity.
    Padiolleau-Lefèvre S; Débat H; Phichith D; Thomas D; Friboulet A; Avalle B
    Immunol Lett; 2006 Feb; 103(1):39-44. PubMed ID: 16325271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly efficient method of preparing human catalytic antibody light chains and their biological characteristics.
    Hifumi E; Honjo E; Fujimoto N; Arakawa M; Nishizono A; Uda T
    FASEB J; 2012 Apr; 26(4):1607-15. PubMed ID: 22205784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
    Johnson G; Moore SW
    J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotypic antibody mimics proteolytic function of parent antigen.
    Ponomarenko NA; Pillet D; Paon M; Vorobiev II; Smirnov IV; Adenier H; Avalle B; Kolesnikov AV; Kozyr AV; Thomas D; Gabibov AG; Friboulet A
    Biochemistry; 2007 Dec; 46(50):14598-609. PubMed ID: 18020454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a serine protease-like catalytic triad on an antibody light chain displayed on the yeast cell surface.
    Okochi N; Kato-Murai M; Kadonosono T; Ueda M
    Appl Microbiol Biotechnol; 2007 Dec; 77(3):597-603. PubMed ID: 17899065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
    Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW
    Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient refolding of a recombinant abzyme : structural and catalytic characterizations.
    Ben Naya R; Matti K; Guellier A; Matagne A; Boquet D; Thomas D; Friboulet A; Avalle B; Padiolleau-Lefèvre S
    Appl Microbiol Biotechnol; 2013 Sep; 97(17):7721-31. PubMed ID: 23250220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of essential residues of human alpha-L-fucosidase and tests of its mechanism.
    Liu SW; Chen CS; Chang SS; Mong KK; Lin CH; Chang CW; Tang CY; Li YK
    Biochemistry; 2009 Jan; 48(1):110-20. PubMed ID: 19072333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the affinity maturation of antibody 48G7.
    Yang PL; Schultz PG
    J Mol Biol; 1999 Dec; 294(5):1191-201. PubMed ID: 10600377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic mechanism of SHCHC synthase in the menaquinone biosynthesis of Escherichia coli: identification and mutational analysis of the active site residues.
    Jiang M; Chen X; Wu XH; Chen M; Wu YD; Guo Z
    Biochemistry; 2009 Jul; 48(29):6921-31. PubMed ID: 19545176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic features of monoclonal antibody i41SL1-2 subunits.
    Hifumi E; Kondo H; Mitsuda Y; Uda T
    Biotechnol Bioeng; 2003 Nov; 84(4):485-93. PubMed ID: 14574707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro abzyme evolution to optimize antibody recognition for catalysis.
    Takahashi N; Kakinuma H; Liu L; Nishi Y; Fujii I
    Nat Biotechnol; 2001 Jun; 19(6):563-7. PubMed ID: 11385462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of catalytic antibody activity by protease processing.
    Ohara K; Munakata H; Hifumi E; Uda T; Matsuura K
    Biochem Biophys Res Commun; 2004 Mar; 315(3):612-6. PubMed ID: 14975745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and characterization of lipase abzyme from phage displayed antibody libraries.
    Leong MK; Chen C; Shar KC; Shiuan D
    Biochem Biophys Res Commun; 2007 Sep; 361(3):567-73. PubMed ID: 17673171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.